Pharmaceutical Research Overview
Ovral G 0.5/0.05 mg is a combination pharmaceutical formulation containing 0.5 mg norgestrel and 0.05 mg ethinylestradiol per tablet. This Pfizer-manufactured preparation represents a classic combination of synthetic progestogen and estrogen compounds extensively documented in hormonal research literature. Researchers at Stroid UK Shop examine this formulation for its established pharmacological profile and dual-hormone composition in controlled laboratory environments.
Laboratory Research Applications
Scientific investigations frequently examine this combination for its well-characterised mechanisms involving estrogen and progestogen receptor interactions. The norgestrel component demonstrates potent progestational activity, while ethinylestradiol provides estrogenic effects in cellular studies. Researchers studying hormonal pathways analyse how these compounds interact at the molecular level with steroid hormone receptors. The formulation’s documented bioavailability makes it valuable for comparative studies alongside other compounds available in our other drugs category. Laboratory protocols often incorporate this preparation when investigating steroid hormone mechanisms, complementing research conducted with SARMs and peptides for comprehensive hormonal studies.
Compound Specifications
| Parameter | Specification |
|---|---|
| Active Compounds | Norgestrel 0.5mg + Ethinylestradiol 0.05mg |
| Manufacturer | Pfizer |
| Presentation | Oral tablets |
| Norgestrel CAS | 6533-00-2 |
| Ethinylestradiol CAS | 57-63-6 |
| Storage Requirements | Room temperature, dry conditions |
| Research Applications | Hormonal mechanism studies |
Research Compliance Statement
This pharmaceutical preparation is exclusively intended for qualified laboratory research purposes. Ovral G tablets are provided solely for in-vitro scientific investigation and analysis by appropriately licensed research institutions. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with all applicable regulations governing pharmaceutical research materials and maintain appropriate laboratory safety protocols during investigation.
